Feasibility and validation of telespirometry in general practice: The Italian "Alliance" study

Respiratory Medicine

Volumn 103, Issue 11, 2009, Pages 1732-1737

  Bonavia, M ^a   Averame, G ^b   Canonica, W ^c   Cricelli, C ^d   Fogliani, V ^e   Grassi, C ^f   Moretti, A M ^e   Ferri, P ^g   Rossi, A ^h   Paggiaro, P L ⁱ  

^a Respiratory Department   (Italy)

^b MedicaLink srl   (Italy)

^c DIMI   (Italy)

^d SIMG   (Italy)

^e Department of Respiratory Diseases ^*  (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g ASTRAZENECA   (United Kingdom)

^h Respiratory Division   (Italy)

ⁱ CISANELLO HOSPITAL   (Italy)

Author keywords

Asthma; COPD; Primary medicine; Spirometry

Indexed keywords

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATION; GENERAL PRACTICE; HUMAN; MEDICAL EDUCATION; PRIORITY JOURNAL; RISK FACTOR; SPIROMETRY; TELEMETRY; VALIDATION PROCESS;

ADULT; ASTHMA; CLINICAL COMPETENCE; FAMILY PRACTICE; FEASIBILITY STUDIES; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; SPIROMETRY; TELEMEDICINE; TREATMENT OUTCOME;

EID: 70349625810     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.05.006     Document Type: Article

References (25)

1. Eder W., Ege M.J., and von Mutius E. The asthma epidemic. N Engl J Med 23 355 (2006) 2226-2235
2. Halbert R.J., Natoli J.L., Gano A., et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006) 523-532
3. Hylkema M.N., Sterk P.J., de Boer W.I., and Postma D.S. Tobacco use in relation to COPD and asthma. Eur Respir J 29 (2007) 438-445
4. Antonicelli L., Bucca C., Neri M., et al. Asthma severity and medical resource utilisation. Eur Respir J 23 (2004) 723-729
5. Chapman K.R., Mannino D.M., Soriano J.B., et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27 (2006) 188-207
6. Selroos O., Lofroos A.B., Pietinalho A., and Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med 98 (2004) 254-262
7. Anthonisen M.R., Skeans M.A., Wise R.A., et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142 (2005) 233-239
8. Gelb A.F., Flynn Taylor C., Shinar C.M., et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 129 (2006) 1492-1499
9. Anthonisen N.R., Wright E.C., and Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 14-20
10. GINA international document. Available from: (November 2006). www.ginasthma.org
11. Pauwels R.A., Buist A.S., Calverly P.M., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
12. Zoia M.C., Corsico A.G., Beccaria M., et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med 99 (2005) 1568-1575
13. Kaminsky D.A., Marcy T.W., Bachand M., and Irvin C.G. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care 50 (2005) 1639-1648
14. O'Dowd L.C., Fife D., Tenhave T., and Panettieri R.A. Attitudes of physicians toward objective measures of airway function in asthma. Am J Med 114 (2003) 391-396
15. Ferguson G.T., Enright P.L., Buist S., and Higgins M.W. Office spirometry for lung health assessment in adults. A consensus statement from the national lung health education program. Chest 117 (2000) 1146-1161
16. Van Schayck C.P., Loozen J.M.C., Wagena E., et al. Detecting patients at high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 324 (2002) 1370-1374
17. Takahashi T., Ichinose M., Inone H., et al. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 8 (2003) 504-508
18. Buffels J., Degryse J., Heyrman J., and Decramer M. Office spirometry significantly improves early detection of COPD in general practice. The DIDASCO study. Chest 125 (2004) 1394-1399
19. Lusuardi M., De Benedetto F., Paggiaro P.L., et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice. Data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest 129 (2006) 844-852
20. Bruderman I., and Abboud S. Telespirometry: novel system for home monitoring of asthmatic patients. Telemed J 3 (1997) 127-133
21. de Toledo P., Jimenez S., and Del Pozo F. A telemedicine system to support a new model for care of chronically ill patients. J Telemed Telecare 8 Suppl. 2 (2002) 17-19
22. Averame G., Bonavia M., Ferri P., et al. Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respir Med (2009 Feb 4) [Epub ahead of print]
23. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
24. 1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 127 (2005) 1560-1564
25. Pellegrino R., Viegi G., Brusasco V., et al. Interpretative strategies for lung function tests. Eur Respir J 26 (2005) 948-968